CRL:NYSE
Charles River Laboratories Intrtnl, Inc.
$307.07
arrow_downward
-1.25%(-3.88) 1D
Oct 6, 1:57:16 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CRL...
Open
$319.80
High
$333.30
Low
$300.01
Mkt. cap
13.69B
Avg. vol.
934.04K
Volume
1.16M
52-wk high
$333.30
52-wk low
$146.20
EPS
-$4.85
Beta
1.40
Shares outstanding
47.74M
No. of employees
19K
Open
$319.80
High
$333.30
Low
$300.01
Mkt. cap
13.69B
Avg. vol.
934.04K
Volume
1.16M
52-wk high
$333.30
52-wk low
$146.20
EPS
-$4.85
Beta
1.40
Shares outstanding
47.74M
No. of employees
19K
News stories
From web sources and news partners
Zacks
·
2 hours ago
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
Profile
Charles River Laboratories International, Incorporated is an American life sciences company and contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides goods and services that support the development of drugs, vaccines, and other therapeutics. Its operations span at least 20 countries, offering research models, drug discovery and safety assessment, and manufacturing and testing services to pharmaceutical, biotechnology, government, and other clients.
Charles River Laboratories is a global provider of non-clinical drug development services, known for its role in toxicology studies, research animal models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of research animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
About Charles River Laboratories Intrtnl, Inc.
CEO-
Employees19K
Founded1947
HeadquartersWilmington, Massachusetts, United States
SectorHealth care
Websitecriver.com